Clene Inc. (CLNN) stock
CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.42+0.20 (+6.21%)
Close on Nov 18, 2026Market cap $43.94MP/E –Yield –
Clene revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Clene's revenue for the twelve months ending Jun 30, 2026 was $197.00K, down 31.1% year over year. For fiscal 2025 it was $200.00K, down 41.5% from the year before. The highest annual figure on record is $723.00K in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $200.00K | -41.5% |
| FY2024 | Dec 31, 2024 | $342.00K | -47.7% |
| FY2023 | Dec 31, 2023 | $654.00K | +38.3% |
| FY2022 | Dec 31, 2022 | $473.00K | -34.6% |
| FY2021 | Dec 31, 2021 | $723.00K | +251.0% |
| FY2020 | Dec 31, 2020 | $206.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $90.00K | +233.3% |
| Q1 FY2026 | Mar 31, 2026 | $15.00K | -81.5% |
| Q4 FY2025 | Dec 31, 2025 | $77.00K | -15.4% |
| Q3 FY2025 | Sep 30, 2025 | $15.00K | -82.8% |
| Q2 FY2025 | Jun 30, 2025 | $27.00K | -70.3% |
| Q1 FY2025 | Mar 31, 2025 | $81.00K | +11.0% |
| Q4 FY2024 | Dec 31, 2024 | $91.00K | -46.5% |
| Q3 FY2024 | Sep 30, 2024 | $87.00K | -19.4% |
| Q2 FY2024 | Jun 30, 2024 | $91.00K | -66.2% |
| Q1 FY2024 | Mar 31, 2024 | $73.00K | -31.8% |
| Q4 FY2023 | Dec 31, 2023 | $170.00K | +385.7% |
| Q3 FY2023 | Sep 30, 2023 | $108.00K | +260.0% |
| Q2 FY2023 | Jun 30, 2023 | $269.00K | +35.2% |
| Q1 FY2023 | Mar 31, 2023 | $107.00K | -2.7% |
| Q2 FY2022 | Jun 30, 2022 | $35.00K | -82.6% |
| Q1 FY2022 | Mar 31, 2022 | $30.00K | -85.9% |
| Q4 FY2021 | Dec 31, 2021 | $199.00K | +586.2% |
| Q3 FY2021 | Sep 30, 2021 | $110.00K | +12.2% |
| Q2 FY2021 | Jun 30, 2021 | $201.00K | +2133.3% |
| Q1 FY2021 | Mar 31, 2021 | $213.00K | +204.3% |
| Q4 FY2020 | Dec 31, 2020 | $29.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $98.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $9.00K | – |
| Q1 FY2020 | Mar 31, 2020 | $70.00K | – |
See a number that looks wrong?